201
Participants
Start Date
May 18, 2022
Primary Completion Date
August 8, 2024
Study Completion Date
August 8, 2024
APRETUDE
Available as intramuscular injection.
Cabotegravir OLI
Available as marketed orally administered tablets.
GSK Investigational Site, The Bronx
GSK Investigational Site, Rochester
GSK Investigational Site, Philadelphia
GSK Investigational Site, Washington D.C.
GSK Investigational Site, Charleston
GSK Investigational Site, Pensacola
GSK Investigational Site, Orlando
GSK Investigational Site, Miami
GSK Investigational Site, Sarasota
GSK Investigational Site, St Louis
GSK Investigational Site, Columbia
GSK Investigational Site, Harlingen
GSK Investigational Site, Los Angeles
GSK Investigational Site, San Francisco
GSK Investigational Site, Seattle
GSK Investigational Site, Bridgeport
GSK Investigational Site, Boston
Lead Sponsor
ViiV Healthcare
INDUSTRY